News

Hexoskin and Halo Health to solve key challenges of clinical trials.

Hexoskin and Halo Health are announcing today a collaboration to solve key challenges in running clinical trials. Combining Hexoskin and Halo Health's technology will offer greater operational efficiency for virtual clinical trials and home monitoring, and offer tools to increase patient engagement.

These new tools will reduce the cost of collecting vital signs data for clinical trials, and will allow patients to participate in medical research from the comfort of their home.

Hexoskin smart garments and its Connected Health Platform are compatible with Halo Health solutions. The two companies will mutually promote their offering to pharmaceutical sponsors to support clinical development.

Halo Health is enabling patient-centric trials to reduce patient and site burden. Its Smart Clinical Trials solution is a digital health platform that provides Remote Patient Monitoring, Patient Engagement, and Workflow Automation. The solution includes an integrated ecosystem of clinical grade sensors and wearables to enable hybrid & virtual trials for various therapeutic areas including cardiology, respiratory and endocrinology.

Pierre-Alexandre Fournier - Chief Executive Officer at Hexoskin: “Medicine's progress depends on being able to better observe patients' outcomes. Anything we can do to lower the cost of data helps accelerate clinical development. This is something that Pharma and Biotech companies need to innovate, but most importantly this is something that we need to do to improve treatments for patients and find new cures for diseases that affect millions of people and their families.” says Pierre-Alexandre Fournier, Chief Executive Officer at Hexoskin. “Combining Halo Health's software with Hexoskin sensors and algorithms reduces the cost of collecting data in clinical trials, with greater flexibility & patient centricity.”

Hexoskin is a pioneer and leader in non-invasive vital signs sensors and remote patient monitoring solutions. Hexoskin Smart Clothing for Men, Women, and Children are clinically validated and its Connected Health Platform is used for health research in cardiology, pulmonology, psychiatry, rare diseases and many other health conditions.

We’re attending  in at HaloHealth's Kiosk on September 17 & 18, 2019! Visit Booth 30 to learn about our joint innovative solutions to solve the key challenges of Clinical-trials! 

Contact Hexoskin to learn more.

Hexoskin Unveils Smart Tools for Connected Health & Patient Remote Monitoring

In 2013, Hexoskin launched a unique solution that revolutionized how we monitor cardiac, respiratory, activity, and sleep data with sensors embedded in a comfortable and machine washable smart garment.

Hexoskin was the first smart clothing compatible with the iPhone. We also opened our API to allow developers and researchers to leverage the value provided by our solutions.

Today, the Hexoskin Connected Health Platform is an end-to-end solution that offers leading-edge sensors, software, and data science tools. It is used by researchers, public and private organizations, athletes, and users who value precise, accessible, and useful health data.

The Hexoskin Connected Health Platform is currently used for Machine Learning and Artificial Intelligence research and projects that will change how patients receive care. Here is an overview of the Hexoskin Connected Health Platform.

 

The Hexoskin Connected Platform is a powerful, yet flexible option that can fit any project sizes. Try it today ! Visit our Health Research Page to learn more about the research and validation conducted with Hexoskin. You can always contact us if you have any questions or need advises on how to leverage the Hexoskin Connected Health Platform for your research or project. 

 

About Hexoskin
Founded in 2006 in Montreal, Carré Technologies Inc. (Hexoskin) is involved in the development of non-invasive sensors, software & applications, data science & AI services. Hexoskin’s mission is to record and organize personal health information and make it accessible and useful.

Hexoskin Application Programming Interface (API) Update

We've done important improvements to the platform over the past year. We've improved the speed of many frequently used functions, and added security and privacy measures that will benefit both developers and users. Some of the improvements mean we'll bring down older versions of the Hexoskin API, including versions supporting OAuth 1.0. That means all authentication will need to be made using OAuth 2.0 starting in April. 

The current Hexoskin API version is 4.5.0.*

*API versions older than 4.0.0 will be retired on Wednesday April 10th, 2019 12PM EDT.

We invite you to go to our Developer page to learn more about developer tools and documentation. For more information, please contact the Hexoskin API team: api@hexoskin.com

About Hexoskin
Founded in 2006 in Montreal, Carré Technologies Inc. (Hexoskin) is involved in the development of non-invasive sensors, software & applications, data science & AI services. Hexoskin’s mission is to record and organize personal health information and make it accessible and useful.

Liquid error: Could not find asset snippets/newsletter-popup.liquid